Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: machine learning approach

. 2022 Apr ; 220 (4) : 219-228. [epub] 20220228

Status PubMed-not-MEDLINE Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid35225756

Grantová podpora
I01 BX003431 BLRD VA - United States
I01 CX000363 CSRD VA - United States
Centro de Investigación en Red de Salud Mental, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Centres de Recerca de Catalunya Programme/Generalitat de Catalunya, Miguel Servet II, Instituto de Salud Carlos III Intramural Research Program of the National Institute of Mental Health Intramural Research Program of the National Institute of Mental Health Investissements d'Avenir National Institute of Drug Abuse Swiss National Foundation NPU I Australian National Health and Medical Research Council INSERM (Institut National de la Santé et de la Recherche Médicale), AP-HP (Assistance Publique des Hôpitaux de Paris), Fondation FondaMental (RTRS Santé Mentale
17-07070S Grantová Agentura České Republiky
P50CA89392 NIH Clinical Center
FOR2107 Deutsche Forschungsgemeinschaft
RI 908/11-1 Deutsche Forschungsgemeinschaft
RI 908/7-1 Deutsche Forschungsgemeinschaft
64410 CIHR - Canada

Odkazy

PubMed 35225756
DOI 10.1192/bjp.2022.28
PII: S0007125022000289
Knihovny.cz E-zdroje

BACKGROUND: Response to lithium in patients with bipolar disorder is associated with clinical and transdiagnostic genetic factors. The predictive combination of these variables might help clinicians better predict which patients will respond to lithium treatment. AIMS: To use a combination of transdiagnostic genetic and clinical factors to predict lithium response in patients with bipolar disorder. METHOD: This study utilised genetic and clinical data (n = 1034) collected as part of the International Consortium on Lithium Genetics (ConLi+Gen) project. Polygenic risk scores (PRS) were computed for schizophrenia and major depressive disorder, and then combined with clinical variables using a cross-validated machine-learning regression approach. Unimodal, multimodal and genetically stratified models were trained and validated using ridge, elastic net and random forest regression on 692 patients with bipolar disorder from ten study sites using leave-site-out cross-validation. All models were then tested on an independent test set of 342 patients. The best performing models were then tested in a classification framework. RESULTS: The best performing linear model explained 5.1% (P = 0.0001) of variance in lithium response and was composed of clinical variables, PRS variables and interaction terms between them. The best performing non-linear model used only clinical variables and explained 8.1% (P = 0.0001) of variance in lithium response. A priori genomic stratification improved non-linear model performance to 13.7% (P = 0.0001) and improved the binary classification of lithium response. This model stratified patients based on their meta-polygenic loadings for major depressive disorder and schizophrenia and was then trained using clinical data. CONCLUSIONS: Using PRS to first stratify patients genetically and then train machine-learning models with clinical predictors led to large improvements in lithium response prediction. When used with other PRS and biological markers in the future this approach may help inform which patients are most likely to respond to lithium treatment.

Biometric Psychiatric Genetics Research Unit Alexandru Obregia Clinical Psychiatric Hospital Romania

Bipolar Center Wiener Neustadt Sigmund Freud University Medical Faculty Austria

Bipolar Disorder Program Institute of Neuroscience Hospital Clinic University of Barcelona IDIBAPS CIBERSAM Spain

Centre for Healthy Brain Ageing School of Psychiatry University of New South Wales Australia

Department of Adult Psychiatry Poznan University of Medical Sciences Poland

Department of Biological Psychiatry and Neuroscience Dokkyo Medical University School of Medicine Japan

Department of Biomedical Sciences University of Cagliari Italy

Department of Clinical Neurosciences Karolinska Institutet Sweden

Department of Genetic Epidemiology in Psychiatry Central Institute of Mental Health Medical Faculty Mannheim University of Heidelberg Germany

Department of Genetic Epidemiology in Psychiatry Central Institute of Mental Health Medical Faculty Mannheim University of Heidelberg Germany; Intramural Research Program National Institute of Mental Health National Institutes of Health US Department of Health and Human Services USA Department of Psychiatry and Behavioral Sciences Johns Hopkins University USA; Institute of Psychiatric Phenomics and Genomics Georg August University Göttingen Germany

Department of Health Sciences Research Mayo Clinic USA and Department of Psychiatry and Psychology Mayo Clinic USA

Department of Medicine Surgery and Dentistry 'Scuola Medica Salernitana' University of Salerno Italy

Department of Mental Health Johns Hopkins Bloomberg School of Public Health USA

Department of Molecular Medicine and Surgery Karolinska Institute Sweden and Center for Molecular Medicine Karolinska University Hospital Stockholm Sweden

Department of Molecular Medicine and Surgery Karolinska Institute Sweden and Center for Molecular Medicine Karolinska University Hospital Stockholm Sweden and Department of Psychiatry and Psychotherapy Medical University of Vienna Austria

Department of Psychiatry and Behavioral Science Juntendo University Graduate School of Medicine Japan

Department of Psychiatry and Behavioral Sciences Johns Hopkins University USA

Department of Psychiatry and Center of Sleep Disorders National Taiwan University Hospital Taiwan

Department of Psychiatry and Department of Child and Adolescent Psychiatry Nagoya University Graduate School of Medicine Japan

Department of Psychiatry and Psychology Mayo Clinic USA

Department of Psychiatry and Psychotherapeutic Medicine Landesklinikum Neunkirchen Austria

Department of Psychiatry and Psychotherapeutic Medicine Research Unit for Bipolar Affective Disorder Medical University of Graz Austria

Department of Psychiatry and Psychotherapy Charité Universitätsmedizin Berlin Campus Charité Mitte Germany

Department of Psychiatry and Psychotherapy Ludwig Maximilian University Munich Germany

Department of Psychiatry and Psychotherapy University Hospital Carl Gustav Carus Medical Faculty Technische Universität Dresden Germany

Department of Psychiatry and Psychotherapy University of Münster Germany; Department of Psychiatry Melbourne Medical School University of Melbourne Australia and The Florey Institute of Neuroscience and Mental Health The University of Melbourne Australia

Department of Psychiatry Dalhousie University Canada

Department of Psychiatry Dokkyo Medical University School of Medicine Japan

Department of Psychiatry Hokkaido University Graduate School of Medicine Japan

Department of Psychiatry Lindner Center of Hope University of Cincinnati USA

Department of Psychiatry Mood Disorders Unit HUG Geneva University Hospitals Switzerland

Department of Psychiatry Psychosomatic Medicine and Psychotherapy University Hospital Frankfurt Germany

Department of Psychiatry University of California San Diego USA

Department of Psychiatry University of California San Diego USA and Department of Psychiatry VA San Diego Healthcare System USA

Department of Psychiatry University of Campania 'Luigi Vanvitelli' Italy; for a full list of Major Depressive Disorder Working Group of the PGC Investigators see the Supplementary Material

Department of Psychiatry University of Perugia Italy

Department of Public Health and Institute of Epidemiology and Preventive Medicine College of Public Health National Taiwan University Taiwan

Discipline of Psychiatry School of Medicine University of Adelaide Australia

Discipline of Psychiatry School of Medicine University of Adelaide Australia and Northern Adelaide Local Health Network Mental Health Services Australia

Douglas Mental Health University Institute McGill University Canada

Epidemiology Branch Division of Intramural Population Health Research Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health USA

INSERM UMR S 1144 Université Paris Diderot Département de Psychiatrie et de Médecine Addictologique AP HP Groupe Hospitalier Saint Louis Lariboisière F Widal France

Institute of Human Genetics University of Bonn and Department of Genomics Life and Brain Center Germany

Institute of Human Genetics University of Bonn and Department of Genomics Life and Brain Center Germany and Human Genomics Research Group Department of Biomedicine University Hospital Basel Switzerland

Institute of Human Genetics University of Bonn and Department of Genomics Life and Brain Center Germany; and Human Genomics Research Group Department of Biomedicine University Hospital Basel Switzerland

Institute of Human Genetics University of Bonn and Department of Genomics Life and Brain Center Germany; Human Genomics Research Group Department of Biomedicine University Hospital Basel Switzerland and Department of Psychiatry University of Basel Switzerland

Institute of Neuroscience and Physiology the Sahlgrenska Academy at the Gothenburg University Sweden and Department of Medical Epidemiology and Biostatistics Karolinska Institutet Sweden

Institute of Psychiatric Phenomics and Genomics Georg August University Göttingen Germany

Institute of Psychiatric Phenomics and Genomics University Hospital LMU Munich Germany and Department of Psychiatry and Psychotherapy Ludwig Maximilian University Munich Germany

Intramural Research Program National Institute of Mental Health National Institutes of Health US Department of Health and Human Services USA

Mental Health Research Group IMIM Hospital del Mar Spain and Centro de Investigación Biomédica en Red de Salud Mental Instituto de Salud Carlos 3 Spain

Molecular Research Center for Children's Mental Development United Graduate School of Child Development Osaka University Japan and Department of Psychiatry Osaka University Graduate School of Medicine Japan

Montreal Neurological Institute and Hospital McGill University Canada

Mood Disorders Center of Ottawa Canada

National Institute of Mental Health Czech Republic

Neuroscience Research Australia Australia and School of Medical Sciences University of New South Wales Australia

Office of Mental Health VA San Diego Healthcare System USA

Program for Quantitative Genomics Harvard School of Public Health USA and HSL Institute for Aging Research Harvard Medical School USA

Psychiatric Genetic Unit Poznan University of Medical Sciences Poland

School of Psychiatry University of New South Wales Australia

Section of Psychiatry Department of Medical Sciences and Public Health University of Cagliari Italy and Department of Pharmacology Dalhousie University Canada

Service de Psychiatrie et Psychologie Clinique Centre Psychothérapique de Nancy Université de Lorraine France

Service de Psychiatrie Hôpital Charles Perrens France

South Australian Academic Health Science and Translation Centre South Australian Health and Medical Research Institute Australia and Program for Quantitative Genomics Harvard School of Public Health USA

The Neuromodulation Unit McGill University Health Centre Canada

Unit of Clinical Pharmacology Hospital University Agency of Cagliari Italy

Unitat de Zoologia i Antropologia Biològica University of Barcelona CIBERSAM Spain

Univ Paris Est Créteil INSERM IMRB Translational Neuropsychiatry AP HP Mondor University Hospital DMU Impact Fondation FondaMental France

Univ Paris Est Créteil INSERM IMRB Translational Neuropsychiatry Fondation FondaMental France

Erratum v

PubMed

Citace poskytuje Crossref.org

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...